Futura Medical (FUM)

London
41.00
-1.00(-2.38%)
  • Volume:
    917,380
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    39.90 - 42.60

FUM Overview

Prev. Close
42
Day's Range
39.9-42.6
Revenue
-
Open
42.1
52 wk Range
12.1-84
EPS
-0.01
Volume
917,380
Market Cap
117.7M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,716,860
P/E Ratio
-
Beta
3.24
1-Year Change
127.03%
Shares Outstanding
287,070,971
Next Earnings Date
13 Sept 2021
What is your sentiment on Futura Medical?
or
Market is currently closed. Voting is open during market hours.

Futura Medical News

Futura Medical Analysis

  • Daily Market News

    EU Market OpenAcross European open markets opened up positively with the FTSE 100 up 1.54% and DAX up 1.78% after further easing from ECB, oil prices rise higher, and US jobless...

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellSellBuy
Technical IndicatorsStrong BuyNeutralStrong SellStrong SellStrong Buy
SummaryBuyNeutralStrong SellStrong SellStrong Buy

Futura Medical Company Profile

Futura Medical Company Profile

Employees
13

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. It specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The Company's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.

Read More
  • More positive news today
    1
    • will this not go up again until we see revenues start to come in, which could be months?
      0
      • I think 50-60p range until the next news comes in. Next news will be receiving the EU Approval Certificate which is due anytime in the next 6 weeks. Just be patient
        0
      • thanks, i bought in near the top so i am trying to work out where the bottom is to lower my average, but it looks like it could go back to the 40s. maybe i will get a bit more at 50
        0
      • Possibly may go into the late 40’s. Would be a good entry point if it goes. I can honestly see this up near £1 in the next few months. Time will tell. Good luck
        0
    • will pull back down
      0
      • why? any news?
        0
    • 100p soon! Buy!
      1
      • this is going to rise & rise !!
        0
        • no pun intended :)
          0
      • very positive about this company.
        2
        • Good idea on the erectile dysfunction gel
          1
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.